CN111380729A - 一种细胞涂片的制备方法及其应用 - Google Patents
一种细胞涂片的制备方法及其应用 Download PDFInfo
- Publication number
- CN111380729A CN111380729A CN201811614478.8A CN201811614478A CN111380729A CN 111380729 A CN111380729 A CN 111380729A CN 201811614478 A CN201811614478 A CN 201811614478A CN 111380729 A CN111380729 A CN 111380729A
- Authority
- CN
- China
- Prior art keywords
- cell
- cancer
- preparing
- cells
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 63
- 239000006285 cell suspension Substances 0.000 claims abstract description 26
- 238000010186 staining Methods 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 6
- 201000010099 disease Diseases 0.000 claims abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 120
- 238000000034 method Methods 0.000 claims description 29
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 17
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 17
- 239000012192 staining solution Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 14
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 11
- 229920002866 paraformaldehyde Polymers 0.000 claims description 11
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 210000000601 blood cell Anatomy 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 7
- 238000000116 DAPI staining Methods 0.000 claims description 6
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 206010009944 Colon cancer Diseases 0.000 claims description 3
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims description 3
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 3
- 208000004736 B-Cell Leukemia Diseases 0.000 claims description 2
- 208000003950 B-cell lymphoma Diseases 0.000 claims description 2
- 206010004593 Bile duct cancer Diseases 0.000 claims description 2
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 2
- 208000022072 Gallbladder Neoplasms Diseases 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 2
- 208000034578 Multiple myelomas Diseases 0.000 claims description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 2
- 206010033128 Ovarian cancer Diseases 0.000 claims description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
- 230000001154 acute effect Effects 0.000 claims description 2
- 208000009956 adenocarcinoma Diseases 0.000 claims description 2
- 208000026900 bile duct neoplasm Diseases 0.000 claims description 2
- 201000010881 cervical cancer Diseases 0.000 claims description 2
- 208000006990 cholangiocarcinoma Diseases 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- 201000004101 esophageal cancer Diseases 0.000 claims description 2
- 201000010175 gallbladder cancer Diseases 0.000 claims description 2
- 206010017758 gastric cancer Diseases 0.000 claims description 2
- 201000010536 head and neck cancer Diseases 0.000 claims description 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims description 2
- 210000005260 human cell Anatomy 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- 230000003211 malignant effect Effects 0.000 claims description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
- 210000004962 mammalian cell Anatomy 0.000 claims description 2
- 201000001441 melanoma Diseases 0.000 claims description 2
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 2
- 201000002528 pancreatic cancer Diseases 0.000 claims description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
- 208000000649 small cell carcinoma Diseases 0.000 claims description 2
- 201000011549 stomach cancer Diseases 0.000 claims description 2
- 206010044412 transitional cell carcinoma Diseases 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims 1
- 201000011061 large intestine cancer Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000011084 recovery Methods 0.000 abstract description 32
- 238000002474 experimental method Methods 0.000 abstract description 10
- 108010052285 Membrane Proteins Proteins 0.000 abstract description 8
- 102000018697 Membrane Proteins Human genes 0.000 abstract description 7
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 12
- 238000007664 blowing Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 239000007853 buffer solution Substances 0.000 description 7
- 238000003125 immunofluorescent labeling Methods 0.000 description 6
- 210000005259 peripheral blood Anatomy 0.000 description 6
- 239000011886 peripheral blood Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 3
- 239000006059 cover glass Substances 0.000 description 3
- 238000011067 equilibration Methods 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2806—Means for preparing replicas of specimens, e.g. for microscopal analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811614478.8A CN111380729A (zh) | 2018-12-27 | 2018-12-27 | 一种细胞涂片的制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811614478.8A CN111380729A (zh) | 2018-12-27 | 2018-12-27 | 一种细胞涂片的制备方法及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111380729A true CN111380729A (zh) | 2020-07-07 |
Family
ID=71214574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811614478.8A Pending CN111380729A (zh) | 2018-12-27 | 2018-12-27 | 一种细胞涂片的制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111380729A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1837772A (zh) * | 2006-04-10 | 2006-09-27 | 暨南大学 | 快速Feulgen染色方法 |
CN101226118A (zh) * | 2007-01-19 | 2008-07-23 | 中国医学科学院肿瘤研究所 | 一种兼容免疫荧光分析的细胞化学染色方法及其用途 |
CN102866052A (zh) * | 2012-10-16 | 2013-01-09 | 百奥迈科生物技术有限公司 | 一种细胞染色试剂盒及其使用方法 |
CN105891511A (zh) * | 2016-05-04 | 2016-08-24 | 中山大学附属第医院 | 用于循环肿瘤细胞和中性粒细胞鉴定的探针及试剂盒 |
-
2018
- 2018-12-27 CN CN201811614478.8A patent/CN111380729A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1837772A (zh) * | 2006-04-10 | 2006-09-27 | 暨南大学 | 快速Feulgen染色方法 |
CN101226118A (zh) * | 2007-01-19 | 2008-07-23 | 中国医学科学院肿瘤研究所 | 一种兼容免疫荧光分析的细胞化学染色方法及其用途 |
CN102866052A (zh) * | 2012-10-16 | 2013-01-09 | 百奥迈科生物技术有限公司 | 一种细胞染色试剂盒及其使用方法 |
CN105891511A (zh) * | 2016-05-04 | 2016-08-24 | 中山大学附属第医院 | 用于循环肿瘤细胞和中性粒细胞鉴定的探针及试剂盒 |
Non-Patent Citations (2)
Title |
---|
张国瑞: "复制选择性腺病毒在肺癌CTCs检测中的应用", 中国优秀硕士学位论文全文数据库 医药卫生科技辑, vol. 2017, no. 03, 15 March 2017 (2017-03-15), pages 14 - 29 * |
汪宇: "循环肿瘤细胞检测预测肝细胞癌微血管侵犯的临床研究", 中国优秀硕士学位论文全文数据库 医药卫生科技辑, no. 2018, pages 19 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hyun et al. | Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics | |
CN105115878A (zh) | 一种循环肿瘤细胞检测试剂盒及其制备方法和应用 | |
CN108611322B (zh) | 乳腺癌循环肿瘤细胞系ctc-3、培养基及ctc-3的建立方法和应用 | |
CN110514489B (zh) | 一种用于癌症监测的特异性全血捕获循环肿瘤细胞的生物涂层及其制备方法 | |
JP2002536635A (ja) | 体液から腫瘍細胞を濃縮するか又は除去する方法及びかかる目的に適したキット | |
CN112899218A (zh) | 一种用于外泌体提取的双重切向流过滤体系及外泌体的制备方法与应用 | |
CN105177005B (zh) | 一种长非编码rna及其应用 | |
CN106970225B (zh) | 一种应用cd45免疫荧光联合cep 8探针鉴定循环肿瘤细胞的试剂盒及其应用 | |
CN106970224B (zh) | 一种应用cd45免疫荧光联合cep探针鉴定循环肿瘤细胞的试剂盒及其应用 | |
CN206787889U (zh) | 一种分离和富集体液成分的装置 | |
US20210170409A1 (en) | Microfluidic chip for circulating tumor cell separation, circulating tumor cell separation method and counting method | |
CN107164332A (zh) | 经干扰序列修饰的TGF‑β1缄默的白血病细胞外泌体及其制备方法和应用 | |
CN106596938B (zh) | 一种循环肿瘤细胞快速检测试剂盒 | |
CN108801746A (zh) | 一种分离和富集体液成分的装置 | |
CN108070561A (zh) | 一种人原代结肠癌细胞的分离及培养方法 | |
CN108624472A (zh) | 一种用于全血中循环肿瘤细胞富集和检测的二氧化硅纳米线阵列芯片及制备方法 | |
CN107299084A (zh) | 发生上皮间质化的循环肿瘤干细胞在肺癌增殖、耐药及转移疾病中的应用 | |
CN108148809A (zh) | 一种从肿瘤细胞上清液中分离外泌体的方法 | |
CN108866064B (zh) | 一种靶向转移性人乳腺癌细胞的核酸适配体及其应用 | |
CN205067292U (zh) | 一种循环肿瘤细胞检测试剂盒 | |
CN113502263B (zh) | 一种促分化培养基及促进cd34阳性细胞分化为血小板的方法 | |
CN111351937A (zh) | 一种mmr蛋白表达缺失检测试剂盒及其检测方法 | |
CN111380729A (zh) | 一种细胞涂片的制备方法及其应用 | |
CN110927369A (zh) | 一种利用tcpp联合cep探针鉴定循环肿瘤细胞的试剂盒及应用 | |
TWI662130B (zh) | 分離循環癌細胞之方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Country or region after: China Address after: 201805 No. 1585 Garden National Road, Anting Town, Jiading District, Shanghai Applicant after: Shanghai Cell Therapy Group Co.,Ltd. Applicant after: SHANGHAI BAIZE MEDICAL LABORATORY Co.,Ltd. Address before: 201805 No. 1585 Garden National Road, Anting Town, Jiading District, Shanghai Applicant before: SHANGHAI CELL THERAPY GROUP Co.,Ltd. Country or region before: China Applicant before: SHANGHAI BAIZE MEDICAL LABORATORY Co.,Ltd. |